SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as the community speculates on upcoming catalysts related to MASH and obesity treatments. Discussions revolve around the potential impact of recent FDA qualifications related to AI-driven analysis in liver biopsies, with many anticipating positive data readouts. Some traders are also eyeing a potential "golden cross" pattern and anticipating significant upward movement.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as the community rallies around the return to OG memes and a growing sense of anticipation for upcoming developments. Discussions revolve around community building, with members expressing strong conviction and encouraging others to join before it's "too late." The focus remains on long-term potential and a collective effort to drive the project forward.

SAIHEAT Ltd. engages in the operation of cryptocurrency mining. It operates Bitcoin for its own account and provides full suite of services, purchase of mining machines, hosting service, and mining pool. The company was founded by Risheng Li on February 2, 2021, and is headquartered in Singapore.

SAIHEAT Ltd. - Ordinary Shares - Class A

SAIHEAT Ltd

SAIH is trending due to speculation around its small modular reactor (SMR) technology potentially being used by Amazon, fueling significant after-hours momentum and a breakout. The stock's low float is a key talking point, with many traders anticipating a potential short squeeze and comparing it to other recent parabolic runners. Community members are actively watching for continued volume and breakout levels, discussing its potential as a play in the AI, energy, and data center space.

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Boston, MA.

Vor Biopharma Inc

VOR is trending due to positive sentiment around a recent Phase 3 clinical study, although opinions are split on whether this will be a long-term catalyst or a short-lived pump, as some traders discuss an upcoming share offering and reverse split. Community members are weighing the potential for a short squeeze against concerns of dilution, with some highlighting institutional ownership and potential undervaluation. The stock's volatile price action and high short interest are fueling active discussions.

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.

Exicure Inc

XCUR is trending following positive Phase 2 data for its multiple myeloma treatment, sparking discussions about the stock's potential and a possible short squeeze. The community is weighing the bullish news against the company's financials, with some expressing concern about potential dilution. Others are comparing it to other low-float runners and anticipating a significant price increase.

AlphaTime Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on September 15, 2021 and is headquartered in New York, NY.

AlphaTime Acquisition Corp

ATMC is trending due to shareholder approval of its merger with HCYC Group, a Hong Kong-based insurance brokerage, triggering a significant after-hours surge. Community discussions highlight the stock's low float and potential for a substantial short squeeze, with some speculating on price targets and comparing it to other recent high-flying low float stocks. The merger approval has sparked investor enthusiasm, driving high trading volume and positioning the combined entity for a new listing.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences ($WVE) is trending due to positive interim data from its Phase 1 trial of WVE-007 for obesity, showing fat loss and muscle preservation. The community is discussing its potential as a multi-day runner and comparing it to other trending tickers, while some are wary of a potential offering. Attention is also focused on SAIH, another ticker that is potentially setting up for a squeeze.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

GPCR is trending due to positive data around its oral GLP-1 aleniglipron, with discussions focusing on its potential as a takeover target, particularly by PFE or MRK. Community members are analyzing the data's strengths, clean liver profile, and implications for competition with LLY. The stock is also seeing increased volume and mentions in AI scanners, adding to the buzz.

The Mosaic Co. engages in the production and marketing of concentrated phosphate and potash crop nutrients. It operates through the following segments: Phosphates, Potash, and Mosaic Fertilizantes. The Phosphates segment is involved in the ownership and operation of mines and production facilities which produce concentrated phosphate crop nutrients and phosphate-based animal feed ingredients, and processing plants which produce concentrated phosphate crop nutrients. The Potash segment includes mining, processing, and selling potash. The Mosaic Fertilizantes segment focuses on mines, chemical plants, crop nutrient blending and bagging facilities, port terminals, and warehouses. The company was founded on March 25, 2004 and is headquartered in Tampa, FL.

Mosaic Company

Mosaic Company ($MOS) is trending as investors weigh the impact of potential potash production cuts and recent hurricane-related operational challenges. Community members are discussing the stock's undervaluation, high dividend yield, and potential for long-term growth in the agricultural sector. Also being considered is how commodity prices and broader market conditions might affect the stock's performance.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMC is trending as the stock experiences a steep drop following a recent earnings report and lowered guidance, prompting discussions about its long-term viability and debt management. The community is analyzing the potential for a turnaround, with some viewing the current price as a buying opportunity due to the company's historical presence and oversold conditions, while others express concern over the dividend cut and overall financial health.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

🧠 $NNBR — The Playbook Nobody’s Talking About 
 
Most see NN Inc. ($NNBR) as a dying industrial micro-cap. 
What they don’t see is that the bones of a turnaround are already sitting inside the company — it just needs the courage to burn down the old model and rebuild for the new era of AI-powered manufacturing. 
 
3️⃣ The Fix — “NN Next: From Labor-Heavy to Lights-Out by 2028” 
 
A one-time, all-in reset: 
 
Massive equity raise ($100–150 M) + new revolving credit line. 
 
Use it to pay down high-interest debt and fund automation. 
 
Plant consolidation &amp; 25-30 % workforce reduction. 
 
Merge redundant facilities in LatAm/EU. 
 
Focus on high-margin plants (U.S. &amp; Poland). 
 
Automation Blitz. 
 
Partner with Fanuc / Siemens / ABB / Rockwell for robotic machining cells, cobots, predictive-maintenance AI. 
 
Target gross margin → 25–30 %. 
 
Rebrand &amp; Redeploy. 
 
Market as a global “precision-capacity platform.” 
 
Grow the marketing &amp; sales side instead of bloated admin layers. 
 
Buy back later.

StockTwits Web

NN Inc

 — The Playbook Nobody’s Talking About 
 
Most see NN Inc. (

) as a dying industrial micro-cap. 
What they don’t see is that the bones of a turnaround are already sitting inside the company — it just needs the courage to burn down the old model and rebuild for the new era of AI-powered manufacturing. 
 
3️⃣ The Fix — “NN Next: From Labor-Heavy to Lights-Out by 2028” 
 
A one-time, all-in reset: 
 
Massive equity raise ($100–150 M) + new revolving credit line. 
 
Use it to pay down high-interest debt and fund automation. 
 
Plant consolidation & 25-30 % workforce reduction. 
 
Merge redundant facilities in LatAm/EU. 
 
Focus on high-margin plants (U.S. & Poland). 
 
Automation Blitz. 
 
Partner with Fanuc / Siemens / ABB / Rockwell for robotic machining cells, cobots, predictive-maintenance AI. 
 
Target gross margin → 25–30 %. 
 
Rebrand & Redeploy. 
 
Market as a global “precision-capacity platform.” 
 
Grow the marketing & sales side instead of bloated admin layers. 
 
Buy back later.